Neuronetics Inc. STIM shares soared 41.08% to $2.06 in after-hours trading on Tuesday following preliminary fourth-quarter 2025 financial results. Revenue Climbs Across Both Segments The medical ...
Please provide your email address to receive an email when new articles are posted on . Anodal transcranial direct current stimulation, with exercise and patient education, improved disability caused ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved Neuronetics’ NeuroStar Advanced Therapy for Mental Health, a transcranial magnetic ...
Transcranial Magnetic Stimulation (TMS) is a safe, non-invasive procedure that delivers magnetic pulses to the brain to change neural activity. It is used to treat mental health disorders, ...